healthy adult men and women
Conditions
Interventions
Sponsors
BHN Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese men and women aged between 20 and 60 at the time of obtaining written consent 2) Persons with a BMI of 23 or more and less than 30 3) Subjects who have received a sufficient explanation of the purpose and content of the research, are capable of giving consent, have fully understood the study, voluntarily applied to participate in the study, and agreed to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1.show severe allergy to the test food 2.with an implantable defibrillator such as a pacemaker 3.have a current or a history of skin diseases, 4.develop severe allergy to metals 5.with severe anemia 6.Currently pregnant or breastfeeding. Or a person who may have such a possibility during the test period 7.Liver/kidney/cardiac disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, brain disease, malignant tumor, immune disease, serious disease such as heart disease, thyroid disease, other metabolic diseases Those who have a serious current disease such as disease or a history 8.are currently undergoing drug treatment, outpatient treatment, diet therapy, or exercise therapy for any serious or chronic disease. 9.are aware of dysmenorrhea or PMS symptoms 10.using health foods, supplements, and medicines that affect test results 11.with current or past drug or alcohol dependence 12.are undergoing hospital visits due to mental disorders (depression, etc.), sleep disorders, etc., or have a history of mental disorders in the past 13.with irregular life rhythm due to night work or shift work 14.lifestyle habits may change during the period from the preliminary examination 15.with extremely irregular lifestyles such as eating and sleeping 16.have an extremely unbalanced diet 17.participated in other clinical trials (research) within 3 months prior to the date of consent acquisition, or those who plan to participate in other clinical trials (research) during the trial period 18.have collected or donated more than 200 mL of blood within 1 month or 400 mL of blood within 3 months prior to the date of obtaining informed consent 19.have difficulty keeping track of various questionnaires 20.judged to be unsuitable as subjects based on clinical test values and measured values at the time of SCR 21.are judged to be inappropriate as subjects by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight, BMI, waist circumference, hip circumference | — |
Countries
Japan
Contacts
Public ContactDaisuke Ochitani
BHN Co., Ltd EBF Business Promotion Office
Outcome results
None listed